EUVIMEDEUVIMED entdecken
Crossref

In vitro anticancer effects of a marine-derived glycosaminoglycan-containing extract from Dicentrarchus labrax scales on human glioblastoma cells

Yunus Aksüt, Nebahat Buşra Aksoy, Aslıhan Şengelen, Eren Yıldırım, Emre Yemişken, Murat Pekmez

Trakya University Journal of Natural Sciences · 2026

DOI: 10.23902/trkjnat.1969474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trakya University Journal of Natural Sciences, 2026. Verfasst von Yunus Aksüt und 5 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Gefördert von: The Scientific Research Projects Coordination Unit of Istanbul University, Türkiye.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Marine ecosystems are an underexplored source of structurally diverse bioactive compounds with therapeutic potential. Among these, glycosaminoglycans (GAGs) have gained attention for their anticoagulant, antioxidant, anti-inflammatory, and antitumor properties. Glioblastoma, the most aggressive malignant primary brain tumor in adults, remains largely incurable due to its high invasiveness, therapeutic resistance, and the protective blood–brain barrier. Therefore, the ongoing need to identify new treatment candidates persists.

Aims

This study aimed to investigate the potential anticancer effects of Dicentrarchus labrax (European seabass) scale extract (DLSE) on human glioblastoma U-87MG cells.

Methods

GAG-containing extracts were prepared from fish scales, and their chemical structures were characterized using Fourier-transform infrared (FTIR) spectroscopy. Cell viability was determined by the MTT assay, migration by scratch wound-healing assay, apoptosis by Hoechst/PI staining, and molecular changes by immunoblotting.

Results

FTIR analysis confirmed the key functional groups consistent with a GAG-like polysaccharide profile. DLSE reduced cell viability in a dose- and time-dependent manner, with an IC50 value of 993 μg/mL at 72 hours. Treatments with 600 and 1000 μg/mL DLSE for 72 hours inhibited cell migration, induced apoptosis, increased the Bax/Bcl-2 ratio, and elevated levels of cleaved caspase-3 and PARP1. DLSE also activated p53/p21-mediated cell-cycle regulatory pathways, and induced ER stress through dose-dependent increases in Grp78, PERK, IRE1α, and cleaved ATF6 levels.

Conclusion

Our findings indicate that GAG-containing DLSE stimulates multiple antitumor pathways in glioblastoma cells. Although further in vivo research and compound fractionation are necessary, marine-derived GAG-rich extracts could be promising adjuncts for glioblastoma therapy.

Förderung

  • The Scientific Research Projects Coordination Unit of Istanbul University, Türkiye

Zitieren

APA

Aksüt, Y., Aksoy, N. B., Şengelen, A., Yıldırım, E., Yemişken, E., & Pekmez, M. (2026). In vitro anticancer effects of a marine-derived glycosaminoglycan-containing extract from Dicentrarchus labrax scales on human glioblastoma cells. Trakya University Journal of Natural Sciences. https://doi.org/10.23902/trkjnat.1969474

Vancouver

Aksüt Y, Aksoy NB, Şengelen A, Yıldırım E, Yemişken E, Pekmez M. In vitro anticancer effects of a marine-derived glycosaminoglycan-containing extract from Dicentrarchus labrax scales on human glioblastoma cells. Trakya University Journal of Natural Sciences. 2026. doi:10.23902/trkjnat.1969474

BibTeX
@article{Akst2026,
  author = {Aksüt, Yunus and Aksoy, Nebahat Buşra and Şengelen, Aslıhan and Yıldırım, Eren and Yemişken, Emre and Pekmez, Murat},
  title = {In vitro anticancer effects of a marine-derived glycosaminoglycan-containing extract from Dicentrarchus labrax scales on human glioblastoma cells},
  journal = {Trakya University Journal of Natural Sciences},
  year = {2026},
  doi = {10.23902/trkjnat.1969474}
}
Kostenlos starten →